Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

AxyS Pharmaceuticals licenses rights to Signal's SERM-beta compounds for cancer indications

Nov. 2, 1999

Development of antisense-containing regimen for malignant melanoma to be fast-tracked

Oct. 29, 1999

Paracure gets notice of allowance for patent covering modified arglabin compounds

Oct. 29, 1999

CPMP gives favorable opinion on Taxotere for advanced non-small cell lung cancer

Oct. 28, 1999

Additional positive data reported for Cell Pathways' exisulind

Oct. 28, 1999

First macrolide LHRH antagonists patented by Abbott

Oct. 28, 1999

New distamycin derivatives developed at Pharmacia & Upjohn for cancer Rx

Oct. 28, 1999

Dramatic results described for STI-571 in CML patients

Oct. 27, 1999

Second-generation virus from Calydon begins clinical testing in prostate cancer

Oct. 27, 1999

Antisense oligonucleotides that modulate human HER-2 expression patented

Oct. 27, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 25, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...